Bicara Therapeutics Inc. Common Stock
$23.43
-1.40 (-5.64%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -10.8%
- 3 Months
- +7.7%
- YTD
- +39.2%
- 1 Year
- +94.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 60.8%
- Largest decline max drawdown, since Aug 2025
- -26.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.40
Own BCAX?
See how BCAX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.